Vanguard Group’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $214K | Sell |
|
|||||
|
2025
Q1 | $243K | Buy |
|
|||||
|
2024
Q4 | $298K | Hold |
|
|||||
|
2024
Q3 | $367K | Hold |
|
|||||
|
2024
Q2 | $377K | Buy |
|
|||||
|
2024
Q1 | $414K | Buy |
|
|||||
|
2023
Q4 | $370K | Buy |
|
|||||
|
2023
Q3 | $355K | Sell |
|
|||||
|
2023
Q2 | $525K | Sell |
|
|||||
|
2023
Q1 | $2.04M | Buy |
|
|||||
|
2022
Q4 | $1.92M | Buy |
|
|||||
|
2022
Q3 | $1.54M | Buy |
|
|||||
|
2022
Q2 | $1.44M | Buy |
|
|||||
|
2022
Q1 | $1.41M | Buy |
|
|||||
|
2021
Q4 | $1.53M | Buy |
|